KRAS and female reproductive organ cancer: The recent TCGA study of 373 endometrial tumors identified the KRAS and PTEN genes as being mutated in 24.6% and 77% of endometrioid tumors respectively, emphasizing the influence of these mutations in gynecologic cancer pathogenesis [14].